Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2019  |  Volume : 32  |  Issue : 3  |  Page : 1094-1098

Evaluation of serum amyloid A protein as a marker in neonatal sepsis


1 Department of Pediatric, Faculty of Medicine, Menoufia University, Menoufia, Egypt
2 Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Menoufia University, Menoufia, Egypt
3 Department of Pediatric, Benha Children Specialized Hospital, Qaliobia, Egypt

Correspondence Address:
Osama M Omran
Quesna, Menoufia Governorate
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/mmj.mmj_35_19

Rights and Permissions

Objective To evaluate the serum amyloid A (SAA) as an early and accurate diagnostic marker in neonatal sepsis. Background The early and efficient diagnosis of neonatal sepsis in high-risk neonates remains a difficult task as the clinical signs are nonspecific, complete blood count parameters and C-reactive protein (CRP) have low sensitivity, also difficulty of its diagnosis may be due to decreased positive values of blood culture and long time which is needed for detection of blood culture results. The SAA protein level in the blood increases earlier and up to 1000-fold in response to inflammation. Participants and methods A case–control study was carried out on 50 septic newborns who were admitted to the Neonatal ICU, Benha Specialized Children Hospital. Patients were subdivided into confirmed (35 cases) and clinical (15 cases) septic groups as well as 25 sex-matched and age-matched neonates as a control group during the study period from April to November 2018. Full assessment of history, clinical examination, complete blood count, CRP, blood culture, and SAA protein were performed for all neonates. Results The mean value of SAA in the confirmed septic group (35 cases with elevated CRP and positive blood cultures) was 77.1 ± 5.5 μg/ml and that in the clinically septic group (15 cases with elevated CRP and negative blood cultures) was 18.5 ± 1.32 μg/ml compared with the control group (4.7 ± 1.1 μg/ml), and this represented a highly statistically significant difference (P = 0.000). Conclusion Serum amyloid A increases significantly in neonates with sepsis in comparison with healthy neonates. Therefore, SAA protein could aid the clinicians in diagnosing most cases of neonatal sepsis.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed28    
    Printed0    
    Emailed0    
    PDF Downloaded10    
    Comments [Add]    

Recommend this journal